Morning Light Bio-Technology Group Co., Ltd. (hereinafter referred to as "the Company") and all members of the board of directors guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or significant omissions.
The board of directors of the Company held the 24th meeting of the 5th board on May 30, 2026, which was convened via personal delivery and mail to all directors on May 23, 2026. The meeting was held in the company conference room, combining in-person and remote participation. The meeting was chaired by Mr. Lu Qingguo, with seven directors required to attend and all seven actually present (Chairman Lu Qingguo, independent directors Niu Hong, Dai Xiaofeng, and Li Liangqiu participated via remote voting). Some senior management personnel of the Company also attended the meeting. The meeting was convened in accordance with the Company Law, the Articles of Association, and other relevant regulations.
After research and discussion by the attending directors, the following proposals were reviewed and approved:
1. Proposal on the Nomination of Non-Independent Directors for the 6th Board of Directors
Given that the term of the 5th board of directors has expired, the board will conduct elections in accordance with the Company Law, the Shenzhen Stock Exchange GEM Listing Rules, the Self-Regulatory Guidelines for Listed Companies on the Shenzhen Stock Exchange No. 2 - Standardized Operations of GEM Listed Companies, and the Articles of Association. The 6th board of directors is proposed to consist of 7 directors, including 3 non-independent directors, 1 employee representative director (to be elected by the employee representative assembly), and 3 independent directors. Until the new board is elected, all current directors will continue to perform their duties.